High materiality7/10
Replimune upgraded to Outperform from Market Perform at BMO Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO Capital upgrades REPL to Outperform; target $16; price $11.2.
- BMO upgrades REPL to Outperform; PT $16; price $11.2.
Key facts
- 01
Target: $16
- 02
Posted price: $11.2
- 03
Analyst firm: BMO Capital
- 04
Analyst: Evan Seigerman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.